Ogovyx cost --YUK

Well, my next PSA will be about 12/8. Assuming a continued increase, Dr. Lam recommends Orgovyx. Biologics, his recommended pharmacy, provides a free 30-day supply (best pusher tradition). They originally told me my co-pay was ZERO. Uh...uh. I had a feeling that information was bogus. You know, they just seemed to hesitate -- kind of unsure -- when they gave me the answer. Anyway, Dr. Lam's office called to tell me my co-pay will be $981 per month. Not too pleased.
Mel
I ran Orgovyx (120mg/day) through my 2023 Part D comparison and the annual cost was around $4300 for all costs including $120 of other meds and premiums. My cost for January would be over $1000 due to $500 deductible and gradually settle down so the total for the year was in the $4K range. All policies I checked were around the same pricing and cash pricing was terrible so no deals. Please use the Medicare comparison tool to help with the annual evaluation given the screwy Medicare drug rules.

Also go to the Orgovyx site https://www.orgovyxpricing.com/ and see if you can get manufacturer help and bypass Part D. It takes some time so start that now. The site claims that 3 of 4 men get it for $85/mo. Good luck.
7/2018 (66yr), PSA 4.1->5.1
8/2018-MRI PI-RADS 5, MRI guided biopsy, 8/14 cores, G7(4+3)
9/2018-CT/Bone scans clear
11/6/18-RALP Surgery
11/2018-Post-Op Path G7(4+3) 5% Tert Gr 5, pT3a pN0 Gr 3, SM, EPE, <3mm
11/2018-Decipher 0.47, Ave Risk
1/2019-Epstein-G9(4+5) Gr5, pT2x, margin vs. incision not clear
4-6/2019 ART 37 days
PSA<0.10: 2/19, 5/19, 8/19, 11/19, 2/20, 6/20, 9/20, 3/21, 10/21, 4/22
And this is why I can't retire.
My work insurance pays 100% for oral cancer drugs .
Orgovyx and Xtandi are about 18,000/month.

My Biopsy
My PSA Curve
Previous PSA
Curve

Treatment Path
My Story

alephnull said...

Orgovyx and Xtandi are about 18,000/month.



I remember telling some family members that I take a drug that costs around $300 dollars a day. The shocked look on their faces was priceless. Then they asked how a drug company can charge so much. I shrugged my shoulders and said it's cancer. They can charge damm well what they please. 🙂
Part I 2015, Age 54. Age now 62
PSA: 20.8 Bx: All cores G7 (4+3)
RALP & Adjuvant RT
Pathology: G8 (4+4)+5
PSA nadir: 0.1, steady increase

Part II 2019
Lupron/Xtandi, PSA: <0.01
2021: Reclast (annual infusion)
Orgovyx and Xtandi were about $13K year when added to my Part D plan.

alephnull - so your employer helps you stay alive so you can work for them?
Apparently...........
I just know there isn't a retirement plan out there for retirees that pays that well.
So, I'll keel over at work someday.

My Biopsy
My PSA Curve
Previous PSA
Curve

Treatment Path
My Story
Lupron isn't inexpensive either...
😢
DOB 1940
Dec 2012: GP felt a nodule and hardened prostate; confirmed by urologist
PSA: 11.9 ng/ml
Biopsy (3/1/2013): Several Gleason 4+5 loci (prostate=45 ml)
Stage: T2c
Transferred to RO
Casodex 1 month; then Lupron 5/13 through 12/14 (18 months total)
Jul-Sep 2013: SBRT (CyberKnife; 3 x 6.5 Gy) followed by IMRT (25 x 1.8 Gy)
Lowest PSA thereafter: 0.1 (3/20/15)
Latest (10/21) PSA = 1.16 ng/ml
Mel,
Not wanting to hijack your Orgovyx post, but there is a lot of YUK with Xtandi too. Please forgive me, but your post got me to Googling.

I found there has been a fair amount of activity going on for the government to use it's "March in Rights" to lower the cost of Xtandi. I guess the government can "march in" because public funds were used in the early development of Xtandi (Enzalutamide).

Astellas has a different view. From one article I read:

** A statement by Astellas claimed that, “while the U.S. government contributed approximately $500,000 to the initial discovery of the molecule that eventually became XTANDI, Astellas has invested more than $1.4 billion to date in research and development efforts for XTANDI.”

A response by KEI said “that is a lot to unpack,” noting that “Charles Sawyers, the lead inventor on the Xtandi patents, is listed as the principal investigator for $27.7 million in NIH-funded projects and $8.3 million in subprojects, beginning in 1985. Michael Jung, another of the Xtandi inventors, was the principal investigator for 42 NIH grants involving $5.99 million….

“Once Xtandi was approved by the FDA on August 31, 2012, it became a commercial and profitable product that has generated more than $20 billion in global sales,” **

If you are interested in such things, Google something like "Xtandi March in Rights." A whole lot of reading will come up. 🙂
Sailor - Lupron injections should be covered under Part B so no cost if you have a decent Medicare plan. Did you have something different?

Mumbo said...
Sailor - Lupron injections should be covered under Part B so no cost if you have a decent Medicare plan. Did you have something different?



My comment wasn't about me; I just wanted to remind our audience that Lupron does carry a substantial cost as well and someone (the 'system') also has to pay for the administration of the shot.

With respect to me, I don't have Medicare B; my Blue Cross/BS plan covered a substantial part of the cost at the time (ten years ago), but I had to pony up more than a few Frappuccinos myself.